CORZ•benzinga•
Oppenheimer Initiates Coverage On Core Scientific with Outperform Rating, Announces Price Target of $15
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 14, 2025 by benzinga